II. Indications
- Symptomatically reduce pulmonary and Peripheral Edema
- Congestive Heart Failure
- Nephrotic Syndrome
- Renal Insufficiency (GFR<30%)
- Other Diuretics (e.g. Thiazide Diuretics) are ineffective at low GFR
- Loop Diuretics (esp. Furosemide) may be used to prevent weight gain between Dialysis runs
- Emergency Management of Pulmonary Congestion (Lasix)
III. Contraindications
IV. Precautions
- All Loop Diuretics except Torsemide need to be dosed twice daily for effect
- Loop Diuretics are associated with significant Electrolyte abnormalities and volume depletion (FDA black box warning)
- Loop Diuretics have a threshold dose, below which they have no effect
- Loop Diuretics have a ceiling dose, above which increasing dose has little effect
- Better in these cases to increase frequency at the ceiling dose
V. Mechanism
- Loop Diuretics are the most potent Diuretics
- Potently inhibits reabsorption of Sodium and chloride
- Action at ascending loop of Henle in glomerulus (Inhibits Na+/K+/Cl+ co-transporter)
- Results in increased urinary Sodium and water excretion
- Direct Venodilation in Pulmonary Edema
- Reduces venous return (Preload)
- Reduces Central Venous Pressure
- Synergistic effect with Morphine and Nitroglycerin
- Reduces Intravascular Volume
- Reduces Cardiac Output
- Beware Hypotension in Myocardial Infarction
VI. Preparations: Relative Potency (40 to 20 to 1)
- Furosemide (Lasix) 40 mg IV (equivalent to 80 mg oral, but variable Bioavailability)
- Torsemide (Demadex) 20 mg IV (equivalent to 20 mg oral)
- Bumetanide (Bumex) 1 mg IV (equivalent to 1 mg oral)
- References
VII. Preparations: Bumetanide (Bumex)
- Oral dosing (adults)
- Start: 0.5 to 1 mg orally twice daily
- Maximum: 10 mg/day
- Duration: 4-6 hours
- Intravenous dosing (adults)
- Start: 1 mg IV/dose (Max: 4-8 mg/dose)
- Intravenous Infusion (adults)
- Load: 1 mg IV
- Rate: 0.5 to 2 mg/hour IV
VIII. Preparations: Furosemide (Lasix)
- Precautions
- Lasix (named for LAst SIX) is only effective for 6 hours
- Optimal dosing is given at least twice daily (patient otherwise is Sodium avid 18 hours/day)
- Half-Life: 1 to 1.5 hours
- Highly variable Bioavailability on oral ingestion (varies between 10 and 90%)
- Increased Bioavailability when taken with meals
- Gastrointestinal absorption is markedly decreased in severe edema
- Contrast with Torsemide which has excellent and consistent Bioavailability
- Higher doses (2-3x) required for Nephrotic Syndrome
- Renal dysfunction results in decreased response and increased Half-Life
- Only 15-20% of Furosemide dose is delivered to the renal tubule in stage 5 CKD
- Oral Dosing (adults)
- Start: 20-40 mg orally daily to twice daily
- Maximum: 600 mg/day (rare to exceed 400 mg/day)
- Peak effect at 1 to 1.5 hours after oral dose
- Duration: 6-8 hours
- Intravenous Dosing
- Intravenous dose is typically one half of oral dose (in exacerbations, the oral dose is often used IV)
- Administer slowly over 1-2 minutes
- Doses higher than 80 mg should infuse slowly to avoid Ototoxicity
- Bolus: 20-40 mg IV (0.5-1.0 mg/kg, max 2 mg/kg)
- Infusion: 0.25 to 0.75 mg/kg/hour
- Onset: Diuresis starts within 10 minutes
- Peak effect in 10-30 minutes
- Duration: 6 hours
- Peak Diuretic effect of repeat dosing is 25% of the first dose
- Compensatory Sodium retention may be overcome by frequent IV doses or continuous infusion
- Maximum effective dose (ceiling dose)
- Chronic Kidney Disease or Nephrotic Syndrome: 80 to 200 mg
- Congestive Heart Failure or Cirrhosis: 40-80 mg
- Intravenous Infusion
- Background
- More effective at maintaining a constant increased Urine Output with less adverse effects (e.g. Ototoxicity)
- Maximum diuresis at 3 hours after continuous infusion started
- Loading dose: 40-200 mg
- Loading doses higher than 80 mg should infuse slowly to avoid Ototoxicity
- Infusion dose
- Start: 10-20 mg/hour IV
- Maximum: 40 mg/hour IV
- Very high dose Furosemide infusions (4 mg/min) risk Ototoxicity
- Background
IX. Preparations: Torsemide (Demadex)
- Background
- Oral Bioavailability 80-90% consistently, even in severe edema (contrast with Furosemide)
- Once daily dosing (contrast with all other Loop Diuretics)
- Half-Life: 3 to 4 hours (doubled in hepatic dysfunction)
- Oral Dosing (adults)
- Start: 10-20 mg orally daily
- Maximum: 200 mg/day
- Duration: 12-16 hours
- Intravenous Dosing (adults)
- Start: 10 mg IV
- Maximum: 100-200 mg/day
- Intravenous Infusion (adults)
- Load: 20 mg
- Rate: 5-20 mg/hour
X. Preparations: Ethacrynic Acid (Edecrin)
- Oral Dosing
- Start: 25 mg orally daily
- Maximum: 200-400 mg divided 2-3 times daily
- Intravenous Dosing
- Start: 0.5 to 1 mg/kg IV up to 100 mg/dose
XI. Adverse Effects
- Risk of central volume depletion (Dehydration, Hypotension and contraction alkalosis)
- Renal dysfunction
- Minimize dosage when starting an ACE Inhibitor
- Avoid NSAIDs
-
Hypersensitivity (esp. Sulfonamide)
- Ethacrynic Acid is the only non-sulfonamide Loop Diuretic
- Electrolyte abnormalities
- Ototoxocity
- Typically reversible (but permanent Deafness may occur)
- Risk Factors
- Higher Loop Diuretic serum concentrations (esp. high dose Furosemide)
- Renal dysfunction
- Concurrent Aminoglycoside use
- More common with Ethacrynic Acid
XII. Mechanism: Loop Diuretic Resistance
-
Renal Insufficiency
- Renal Toxin (e.g. NSAID) decreases GFR
- NSAIDs
- Decreased Diuretic oral absorption
- Structural changes in the Kidney
- Normal aging
- Distal tubular hypertrophy (long term use)
- Consider adding a Thiazide Diuretic
- Counters distal tubular reabsorption
- Significantly boosts Loop Diuretic effect
- Increased Dietary Sodium intake
XIII. Drug Interactions
- Warfarin
-
Cyclosporine
- Cyclosporine decreases Uric Acid excretion, and increased gout risk when used with Furosemide
Images: Related links to external sites (from Bing)
Related Studies
furosemide (on 12/21/2022 at Medicaid.Gov Survey of pharmacy drug pricing) | ||
FUROSEMIDE 10 MG/ML SOLUTION | Generic | $0.09 per ml |
FUROSEMIDE 20 MG TABLET | Generic | $0.03 each |
FUROSEMIDE 40 MG TABLET | Generic | $0.03 each |
FUROSEMIDE 80 MG TABLET | Generic | $0.05 each |
bumetanide (on 12/21/2022 at Medicaid.Gov Survey of pharmacy drug pricing) | ||
BUMETANIDE 0.5 MG TABLET | Generic | $0.22 each |
BUMETANIDE 1 MG TABLET | Generic | $0.23 each |
BUMETANIDE 2 MG TABLET | Generic | $0.42 each |
torsemide (on 12/21/2022 at Medicaid.Gov Survey of pharmacy drug pricing) | ||
TORSEMIDE 10 MG TABLET | Generic | $0.08 each |
TORSEMIDE 100 MG TABLET | Generic | $0.27 each |
TORSEMIDE 20 MG TABLET | Generic | $0.08 each |
TORSEMIDE 5 MG TABLET | Generic | $0.07 each |
ethacrynic acid (on 11/23/2022 at Medicaid.Gov Survey of pharmacy drug pricing) | ||
ETHACRYNIC ACID 25 MG TABLET | Generic | $2.53 each |